Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon regulatory factor 3 (IRF3) is a constitutively expressed transcription factor in the cytoplasm, activated by viral infection or other innate immune stimuli[1][9]. It undergoes phosphorylation at multiple serine/threonine residues by kinases such as TBK1 and IKKε, leading to dimerization and translocation into the nucleus, where it binds DNA at interferon-stimulated response elements (ISREs) to induce type I interferon and ISG transcription[1][4][6][9]. IRF3 is essential in mounting antiviral defenses and fine-tuning inflammatory responses, and aberrations in its activity are linked to pathologies including viral susceptibility, chronic inflammation, and certain cardiovascular injuries[4][6][9].
Inhibition of phosphorylation (preventing IRF3 activation and nuclear translocation); Blockade of dimerization (preventing transcriptional activity); Modulation of upstream kinases (TBK1, IKKε) or signaling adaptors (STING, MAVS, TRIF)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon regulatory factor 3 (IRF3).